Anti-inflammatory and analgesic potential of hydrolyzed extract of Agave sisalana Perrine ex Engelm., Asparagaceae;Potencial anti-inflamatório e analgésico do extrato hidrolisado de Agave sisalana Perrine ex Engelm, Asparagaceae

Revista Brasileira de Farmacognosia

Volumn 20, Issue 3, 2010, Pages 376-381

  Dunder, Ricardo J ^a   Quaglio, Ana E V ^b   Maciel, Rubens P ^b   Luiz Ferreira, Anderson ^a   Almeida, Ana C A ^a   Takayama, Christiane ^a   de Faria, Felipe M ^a   Souza Brito, Alba R M ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Agave sisalana; Analgesic; Anti inflammatory; Asparagaceae agavoideae; Hemolytic

Indexed keywords

AGAVE SISALANA EXTRACT; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; ANTINOCICEPTIVE AGENT; CARRAGEENAN; DEXAMETHASONE; HEMOLYTIC AGENT; INDOMETACIN; PLANT EXTRACT; SAPONIN; UNCLASSIFIED DRUG; XYLENE;

AGAVACEAE; AGAVE SISALANA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; GRANULOMA; HEMOLYSIS; HYDROLYSIS; MALE; NONHUMAN; OTITIS; PAW EDEMA; RAT; SINGLE DRUG DOSE;

EID: 77957568886     PISSN: 0102695X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0102-695X2010000300014     Document Type: Article

References (29)

1. Barnes JP, 2006. How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Brit J Pharmacol 148: 245-254.
2. Bighetti EJ, Hiruma-Lima CA, Gracioso JS, Brito ARMS 1999. Anti-inflammatory and antinociceptive effects in rodents of the essential oil of Croton cajucara Benth. J Pharm Pharmacol 51: 1447-1453.
3. Da Silva BP, De Sousa AC, Silva GM, Mandes TP, Parente JP 2002. A new bioactive steroidal saponin from Agave attenuata. Z. Naturforsch C 57: 423-428.
4. Ding Y, Chen YY, Wang DZ, Yang CR 1989. Steroidal saponins from a cultivated form of Agave salana. Phytochemistry 28: 2787-2791.
5. Ferreira da Silva ORR, Macedo Beltrão NE 1999. O agronegócio de sisal no Brasil, 1o Ed. Embrapa: Campina Grande-PB, p. 25.
6. Flower R, Gryglewski, Herbaczynska-Cedro K, Vane JR 1972. Effects of anti-inflammatory drugs on prostaglandins biosynthesis. Nat New Biol 238: 104-106.
7. Flower RJ 2006. Prostaglandins, bioassay and inflammation. Brit J Pharmacol 147: 182-192.
8. Garcia MD, Quilez AM, Saenz MT, Martinez-Dominguez ME 1999. Anti-inflammatory activity of Agave intermixta Trel and Cissus sicyoides L., species used in the Caribbean traditional medicine. J Ethnopharmacol 71: 395-400.
9. Gepdiremen A, Mshvildadze V, Süleyman H, Elias R 2004. Acute and chronic antiinflammatory effects of Hedera colchica in rats. J Etnopharmacol 94: 191-195.
10. Gilman GA, Goodman LS, Rall TW, Murad F 2001 Goodman and Gilman's Pharmacological Basis of Therapeutics 8th Ed., MacMillan, New York.
11. Gilroy DW, Newson J, Sawmynaden P, Willoughby DA, Croxtall JD 2004. A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammation. FASEB J 18: 489-498.
12. Henriques MGMO, Silva PMR, Martins MA, Flores CA, Cunha FQ, Assreuy-Filho J, Cordeiro RSB 1987. Mouse paw edema. A new model for inflammation. Braz J Med Biol Res 20: 243-249.
13. Koster R, Anderson M, De Beer EJ 1959. Acetic acid for analgesic screening. Fed Proc 18: 412-418.
14. Kummer CL, Coelho TC 2002. Antiinflamatórios não esteróides inibidores da ciclooxigenase-2 (COX-2): Aspectos atuais. Rev Bras Anestesiol 52: 498-512.
15. Lacaille-Dubois MA, Wagner H 1996. A review of the biological and pharmacological acivities of saponins. Phytomedicine 2: 363-386.
16. Lawrence T, Willoughby DA, Gilroy DW 2002. Antiinflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev 2: 787-795.
17. Little RJ, Bodor N, Loftsson T 1999. Soft drugs based on hydrocortisone: the inactive metabolite approach and its application to steroidal agents. Pharm Res 16: 961-967.
18. Oda K, Matsuda H, Murakami T, Katayama S, Ogitani T, Yoshikawa M. 2000. Adjuvant and haemolytic activies of 47 saponins derived from medicinal and food plants. Biol Chem 381: 67-74.
19. Oashi MC 1999. Estudo da cadeia produtiva como subsídio para pesquisa e desenvolvimento do agronegócio do sisal na Paraíba. Tese de Doutorado, Universidade Federal de Santa Catarina, 1999.
20. Peana AT, Moretti MD, Manconi V, Desole G, Pippia P 1997. Anti-inflammatory activity of aqueous extracts and steroidal sapogenins of Agave americana. Planta Med 63: 199-202.
21. Santos WR, Bernardo RR, Peçanha LM, Palatnick M, Parente JP, Palatnick CS 1997. Hemolytic activities of plants saponins and adjuvants. Effects of Periantra mediterranea saponin on the humoral response to the FML antigen of Leismania donovani. Vaccine 15: 1024-1029.
22. Sun HX 2006. Hemolytic activities and adjuvants effect of Bupleurum chinese saponins on the immune responses to ovoalbumin in mices. Vaccine 24: 1324-1331.
23. Swingle KF, Shideman FE 1972. Phases of the inflammatory response to subcutaneous implantation of cotton pellet and their modification by certain antiinflamatory drugs. J Pharmacol Exp Ther 183: 226-234.
24. Tyler VE, Brady LR, Robbers JE, 1988. Pharmacognosy. Lea & Febriger, Philadelphia, PA.
25. Vonkerman HE, Van de Laar MAFJ 2008. Nonsteroidal antiinflammatory drugs: adverse effects and their prevention. Semin Arthritis Rheu 39: 294-312.
26. Winter CA, Risley EA, Nuss GW 1962. Carrageenan induced edema in hind paw of rat as an assay for anti-inflammatory drugs. Prog Soc Biol Med 11: 544-547.
27. Yedgar S, Cohen Y, Shoseyov D 2006. Control of phospholipase A2 activities for the treatment of inflammatory conditions. Biochim Biophys Acta 1761: 1373-1382.
28. Yoshiki Y, Takagi S, Watanabe M, Okubo K 2005. Fractionation of soybean functional glycosides from soy-waste based on the chemical reaction of soyasaponinßg. Food Chem 93: 591-597.
29. Young JM, De Young LM 1989. Cutaneous models of inflammation for the evaluation of topical and systemic pharmacological agents. In: Chang JY, Lewis AJ, eds. Pharmacological Methods in the Control of Inflammation. New York: Alan R. Liss, p. 215-231.